000279362 001__ 279362
000279362 005__ 20250828101646.0
000279362 0247_ $$2doi$$a10.1177/23969873241282875
000279362 0247_ $$2pmid$$apmid:39359171
000279362 0247_ $$2pmc$$apmc:PMC11556533
000279362 0247_ $$2ISSN$$a2396-9873
000279362 0247_ $$2ISSN$$a2396-9881
000279362 037__ $$aDZNE-2025-00739
000279362 041__ $$aEnglish
000279362 082__ $$a610
000279362 1001_ $$0P:(DE-2719)2811949$$aBode, Felix J$$b0
000279362 245__ $$aHome and workforce reintegration one year after thrombectomy in acute stroke patients.
000279362 260__ $$aLondon$$bSage Publishing$$c2025
000279362 3367_ $$2DRIVER$$aarticle
000279362 3367_ $$2DataCite$$aOutput Types/Journal article
000279362 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756299997_10796
000279362 3367_ $$2BibTeX$$aARTICLE
000279362 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279362 3367_ $$00$$2EndNote$$aJournal Article
000279362 520__ $$aEndovascular thrombectomy (EVT) combined with intravenous thrombolysis is the current standard treatment for acute large-vessel occlusion stroke. Beyond clear clinical benefits in the acute and post-acute phases, comprehensive evaluations of long-term outcomes, including home and workforce reintegration, remain limited. This study aimed to assess home and workforce reintegration 1 year post-EVT in a cohort of acute stroke patients and explore their association with health-related quality of life (HRQoL).We conducted a prospective observational study of 404 patients undergoing EVT at a tertiary university medical center between October 2019 and December 2021. Patients' functional outcomes were evaluated using the modified Rankin Scale (mRS), and HRQoL was assessed via the European Quality of Life Five Dimension Scale (EQ-5D). Data on occupational and living status were collected through standardized telephone interviews at 3- and 12-months post-treatment.Of 357 patients with 12-month follow-up data, 33.6% had a favorable outcome (mRS 0-2). Among stroke survivors, the rate of home reintegration without nursing care was 42.1%, and workforce reintegration among previously employed patients was 43.3% at 12 months. Both outcomes were significantly associated with improved HRQoL. Lower neurological deficits and younger age were predictive of successful home and workforce reintegration.One year post-EVT, approximately 40%-50% of acute stroke patients successfully reintegrate into home and work settings. These findings underscore the need for ongoing support tailored to improving long-term reintegration and quality of life for stroke survivors.Data access statement:The data supporting the findings of the study are available from the corresponding author upon reasonable request and in accordance to European data privacy obligations.
000279362 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000279362 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000279362 650_7 $$2Other$$aThrombectomy
000279362 650_7 $$2Other$$afunctional outcome
000279362 650_7 $$2Other$$aischemic stroke
000279362 650_7 $$2Other$$aquality of life
000279362 650_7 $$2Other$$aworkforce reintegration
000279362 650_2 $$2MeSH$$aHumans
000279362 650_2 $$2MeSH$$aMale
000279362 650_2 $$2MeSH$$aFemale
000279362 650_2 $$2MeSH$$aQuality of Life
000279362 650_2 $$2MeSH$$aAged
000279362 650_2 $$2MeSH$$aThrombectomy: methods
000279362 650_2 $$2MeSH$$aMiddle Aged
000279362 650_2 $$2MeSH$$aProspective Studies
000279362 650_2 $$2MeSH$$aStroke: surgery
000279362 650_2 $$2MeSH$$aStroke Rehabilitation
000279362 650_2 $$2MeSH$$aTreatment Outcome
000279362 650_2 $$2MeSH$$aAged, 80 and over
000279362 7001_ $$aZadon, Nina A$$b1
000279362 7001_ $$0P:(DE-2719)9003181$$aAsperger, Hannah$$b2$$udzne
000279362 7001_ $$0P:(DE-2719)9002283$$aBeckonert, Niklas M$$b3
000279362 7001_ $$0P:(DE-2719)9003076$$aEbrahimi, Taraneh$$b4$$udzne
000279362 7001_ $$aNitsch, Louisa$$b5
000279362 7001_ $$0P:(DE-2719)9001884$$aNordsiek, Julia$$b6
000279362 7001_ $$00000-0002-8980-9337$$aMeissner, Julius N$$b7
000279362 7001_ $$0P:(DE-2719)9002936$$aShirvani, Omid$$b8
000279362 7001_ $$0P:(DE-2719)9000778$$aStösser, Sebastian$$b9$$udzne
000279362 7001_ $$0P:(DE-2719)9002386$$aThielscher, Christian$$b10$$udzne
000279362 7001_ $$aDorn, Franziska$$b11
000279362 7001_ $$aLehnen, Nils C$$b12
000279362 7001_ $$0P:(DE-2719)2810273$$aPetzold, Gabor C$$b13$$udzne
000279362 7001_ $$00000-0001-5818-5392$$aWeller, Johannes M$$b14
000279362 773__ $$0PERI:(DE-600)2851287-X$$a10.1177/23969873241282875$$gVol. 10, no. 2, p. 416 - 421$$n2$$p416 - 421$$tEuropean stroke journal$$v10$$x2396-9873$$y2025
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739%20SUP.doc
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739%20SUP.docx
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739%20SUP.odt
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739%20SUP.pdf
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739_Restricted.pdf
000279362 8564_ $$uhttps://pub.dzne.de/record/279362/files/DZNE-2025-00739_Restricted.pdf?subformat=pdfa$$xpdfa
000279362 909CO $$ooai:pub.dzne.de:279362$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000279362 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR STROKE J : 2022$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR STROKE J : 2022$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2024-12-28$$wger
000279362 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-28
000279362 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
000279362 9141_ $$y2025
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2811949$$aExternal Institute$$b0$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003181$$aExternal Institute$$b2$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002283$$aExternal Institute$$b3$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003076$$aExternal Institute$$b4$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002936$$aExternal Institute$$b8$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9000778$$aExternal Institute$$b9$$kExtern
000279362 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002386$$aExternal Institute$$b10$$kExtern
000279362 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810273$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000279362 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000279362 9201_ $$0I:(DE-2719)1013020$$kAG Petzold$$lVascular Neurology$$x0
000279362 980__ $$ajournal
000279362 980__ $$aVDB
000279362 980__ $$aI:(DE-2719)1013020
000279362 980__ $$aUNRESTRICTED
000279362 9801_ $$aFullTexts